Notch 1 also underlies the chemosensitivity to oxaliplatin, 5-FU, and SN-38 (active metabolite of irinotecan) in CRC cells (HCT116, SW620, SW480, and HT29) [39]. Here, NOTCH1 is linked to colorectal carcinoma.